Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-11-30 · accession 0001415889-24-028073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-03 | 2024-11-30 | YARW | Domzalski David | Pres AND CEO, Dir | A - Grant | $2.10 | +3,901 | 500.6K | +0.8% | +$8,192 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-30 | A | A | 3,901 | $2.10 | 500,597 | D | — | — |